Teva Pharmaceutical Industries Limited
$40.63B- Market cap
- $42.37B
- Debt
- +$1.82B
- Cash
- −$3.56B
Capital structure 96% equity / 4% debt · EV / Revenue 2.35x · EV / EBITDA 9.92x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: TEVA stock price at discount vs DELL $36.36 current versus $73.07 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DELL's multiple
Implied fair value · at TEVA's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Value edge
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: TEVA FY 2025 (ended Dec 31, 2025) · DELL FY 2026 (ended Jan 30, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 96% equity / 4% debt · EV / Revenue 2.35x · EV / EBITDA 9.92x
Capital structure 90% equity / 10% debt · EV / Revenue 3.24x · EV / EBITDA 31.72x
DELL carries the larger enterprise value at $368.13B against $40.63B; TEVA trades on the lower EV / Revenue multiple (2.35x vs 3.24x); TEVA on the lower EV / EBITDA (9.92x vs 31.72x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
TEVA PHARMACEUTICAL INDUSTRIES LIMITED · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Dell Technologies Inc. · implied price per share
Bear
$107.69
Base
$128.82
Bull
$157.32
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.23x
-15.99x
Net debt / EBITDA
Leverage against operating earnings
-0.42x
2.41x
Cash and equivalents
Liquid reserves on the balance sheet
$3.56B
$11.53B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$1.82B
$39.49B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe TEVA can sustain its strong margins while improving leverage and avoiding distress, then the stock looks worth holding or accumulating because the current price is below the P/E-implied value and within the historical valuation band.
TEVA’s current price of $34.64 sits well below the P/E-implied value of $54.97, implying 58.7% upside, but that valuation signal is not confirmed cleanly by the rest of the data. The stock is also above the lower end of both DELL-implied range and the DCF range, which suggests the market is already discounting some of the upside.
Supporting Metrics